Literature DB >> 30917945

Approaches for probing and evaluating mammalian sphingolipid metabolism.

Justin M Snider1, Chiara Luberto2, Yusuf A Hannun3.   

Abstract

Sphingolipid metabolism plays a critical role in regulating processes that control cellular fate. This dynamic pathway can generate and degrade the central players: ceramide, sphingosine and sphingosine-1-phosphate in almost any membrane in the cell, adding an unexpected level of complexity in deciphering signaling events. While in vitro assays have been developed for most enzymes in SL metabolism, these assays are setup for optimal activity conditions and can fail to take into account regulatory components such as compartmentalization, substrate limitations, and binding partners that can affect cellular enzymatic activity. Therefore, many in-cell assays have been developed to derive results that are authentic to the cellular situation which may give context to alteration in SL mass. This review will discuss approaches for utilizing probes for mammalian in-cell assays to interrogate most enzymatic steps central to SL metabolism. The use of inhibitors in conjunction with these probes can verify the specificity of cellular assays as well as provide valuable insight into flux in the SL network. The use of inhibitors specific to each of the central sphingolipid enzymes are also discussed to assist researchers in further interrogation of these pathways.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30917945      PMCID: PMC6498843          DOI: 10.1016/j.ab.2019.03.014

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  246 in total

1.  The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells.

Authors:  Carolyn Loveridge; Francesca Tonelli; Tamara Leclercq; Keng Gat Lim; Jaclyn S Long; Evgeny Berdyshev; Rothwelle J Tate; Viswanathan Natarajan; Stuart M Pitson; Nigel J Pyne; Susan Pyne
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

Review 2.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

3.  Low nanogram range quantitation of diglycerides and ceramide by high-performance liquid chromatography.

Authors:  M Previati; L Bertolaso; M Tramarin; V Bertagnolo; S Capitani
Journal:  Anal Biochem       Date:  1996-01-01       Impact factor: 3.365

Review 4.  Inhibitors of sphingolipid metabolism enzymes.

Authors:  Antonio Delgado; Josefina Casas; Amadeu Llebaria; José Luís Abad; Gemma Fabrias
Journal:  Biochim Biophys Acta       Date:  2006-09-01

5.  Specificity of inhibitors of serine palmitoyltransferase (SPT), a key enzyme in sphingolipid biosynthesis, in intact cells. A novel evaluation system using an SPT-defective mammalian cell mutant.

Authors:  K Hanada; M Nishijima; T Fujita; S Kobayashi
Journal:  Biochem Pharmacol       Date:  2000-05-15       Impact factor: 5.858

6.  Assay of glucocerebrosidase using a fluorescent analogue of glucocerebroside for the diagnosis of Gaucher disease.

Authors:  M Midorikawa; S Okada; T Yutaka; H Yabuuchi; M Naoi; K Kiuchi; K Yagi
Journal:  Biochem Int       Date:  1985-09

7.  Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells.

Authors:  J Preiss; C R Loomis; W R Bishop; R Stein; J E Niedel; R M Bell
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

8.  ORMDL/serine palmitoyltransferase stoichiometry determines effects of ORMDL3 expression on sphingolipid biosynthesis.

Authors:  Deanna Siow; Manjula Sunkara; Teresa M Dunn; Andrew J Morris; Binks Wattenberg
Journal:  J Lipid Res       Date:  2015-02-17       Impact factor: 5.922

9.  High-precision fluorescence assay for sphingomyelinase activity of isolated enzymes and cell lysates.

Authors:  A Loidl; R Claus; H P Deigner; A Hermetter
Journal:  J Lipid Res       Date:  2002-05       Impact factor: 5.922

10.  Fluorescent, short-chain C6-NBD-sphingomyelin, but not C6-NBD-glucosylceramide, is subject to extensive degradation in the plasma membrane: implications for signal transduction related to cell differentiation.

Authors:  J W Kok; T Babia; K Klappe; D Hoekstra
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

View more
  4 in total

1.  Monitoring the Sphingolipid de novo Synthesis by Stable-Isotope Labeling and Liquid Chromatography-Mass Spectrometry.

Authors:  Dominik Wigger; Erich Gulbins; Burkhard Kleuser; Fabian Schumacher
Journal:  Front Cell Dev Biol       Date:  2019-10-01

2.  Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma.

Authors:  Yonghao Sun; Yingkun Xu; Xiangyu Che; Guangzhen Wu
Journal:  Front Cell Dev Biol       Date:  2022-06-29

3.  Ceramide synthase 6 mediates sex-specific metabolic response to dietary folic acid in mice.

Authors:  Keri Barron; Besim Ogretmen; Natalia Krupenko
Journal:  J Nutr Biochem       Date:  2021-08-04       Impact factor: 6.048

4.  Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis.

Authors:  Dan Zhao; Laela M Hajiaghamohseni; Xiang Liu; Zdzislaw M Szulc; Aiping Bai; Alicja Bielawska; James S Norris; Sakamuri V Reddy; Yusuf A Hannun; Azizul Haque
Journal:  Cytokine       Date:  2020-07-29       Impact factor: 3.861

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.